comparemela.com

Latest Breaking News On - Biopharma dive - Page 6 : comparemela.com

Acorda files for bankruptcy, reveals asset sale plan

Stalking horse bidder Merz Therapeutics could get rights to Acorda’s three marketed drugs if its $185 million proposal holds.

Germany
Finland
German
Ron-cohen
Acorda-therapeutics
Merz-group
Drug-administration
Us-supreme-court
Dive-brief
Scopia-capital-management
Civitas-therapeutics
Merz-therapeutics

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma

Nasdaq
Dive-brief
Arch-venture-partners
San-diego-based
Kyverna-therapeutics
Alto-neuroscience
Biopharma-dive
Versant-ventures-backed-contineum-therapeutics
Renaissance-capital

Boundless Bio breaks IPO lull with $100M fundraise

The startup’s performance will test investors’ appetite for early-stage drugmakers, as Boundless has only advanced as far as Phase 1 clinical trials.

Nasdaq
Dive-brief
Arch-venture-partners
San-diego-based
Kyverna-therapeutics
Alto-neuroscience
Biopharma-dive
Versant-ventures-backed-contineum-therapeutics
Renaissance-capital

vimarsana © 2020. All Rights Reserved.